tranexamic acid has been researched along with Hypercoagulability in 9 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Gosselin, AR | 1 |
| White, NJ | 1 |
| Bargoud, CG | 1 |
| Hanna, JS | 1 |
| Tutwiler, V | 1 |
| Barzilai, M | 1 |
| Kirgner, I | 1 |
| Steimatzky, A | 1 |
| Salzer Gotler, D | 1 |
| Belnick, Y | 1 |
| Shacham-Abulafia, A | 1 |
| Avivi, I | 1 |
| Raanani, P | 1 |
| Yahalom, V | 1 |
| Nakav, S | 1 |
| Varon, D | 1 |
| Yussim, E | 1 |
| Bachar, GN | 1 |
| Spectre, G | 1 |
| Benhamou, D | 1 |
| Keita, H | 1 |
| Ducloy-Bouthors, AS | 1 |
| Al-Samkari, H | 1 |
| Jing, J | 1 |
| Du, Z | 1 |
| Wen, Z | 1 |
| Jiang, B | 1 |
| He, B | 1 |
| Bistervels, IM | 1 |
| Scheres, LJJ | 1 |
| Hamulyák, EN | 1 |
| Middeldorp, S | 1 |
| Harvin, JA | 1 |
| Peirce, CA | 1 |
| Mims, MM | 1 |
| Hudson, JA | 1 |
| Podbielski, JM | 1 |
| Wade, CE | 1 |
| Holcomb, JB | 1 |
| Cotton, BA | 1 |
| Appelmann, I | 1 |
| Kreher, S | 1 |
| Parmentier, S | 1 |
| Wolf, HH | 1 |
| Bisping, G | 1 |
| Kirschner, M | 1 |
| Bergmann, F | 1 |
| Schilling, K | 1 |
| Brümmendorf, TH | 1 |
| Petrides, PE | 1 |
| Tiede, A | 1 |
| Matzdorff, A | 1 |
| Griesshammer, M | 1 |
| Riess, H | 1 |
| Koschmieder, S | 1 |
| Idbaih, A | 1 |
| Crassard, I | 1 |
| Vahedi, K | 1 |
| Guichard, JP | 1 |
| Woimant, F | 1 |
4 reviews available for tranexamic acid and Hypercoagulability
| Article | Year |
|---|---|
Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
Topics: Anticoagulants; Autoantibodies; Betacoronavirus; Blood Proteins; Cerebrovascular Disorders; Contrain | 2020 |
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Topics: Anemia; Angiogenesis Inhibitors; Anticoagulants; Antifibrinolytic Agents; Clinical Trials as Topic; | 2021 |
Sex matters: Practice 5P's when treating young women with venous thromboembolism.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low- | 2019 |
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis
Topics: Anticoagulants; Antineoplastic Agents; Blood Coagulation Factors; Blood Loss, Surgical; Blood Transf | 2016 |
1 trial available for tranexamic acid and Hypercoagulability
| Article | Year |
|---|---|
The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis.
Topics: Adult; Antifibrinolytic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospita | 2015 |
4 other studies available for tranexamic acid and Hypercoagulability
| Article | Year |
|---|---|
Hyperfibrinolysis drives mechanical instabilities in a simulated model of trauma induced coagulopathy.
Topics: Blood Coagulation Disorders; Fibrin; Fibrinogen; Hemodilution; Hemostatics; Humans; Thrombophilia; T | 2022 |
Prothrombin Complex Concentrate before Urgent Surgery in Patients Treated with Rivaroxaban and Apixaban.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; B | 2020 |
Dynamic changes of urinary proteins in a rat model of acute hypercoagulable state induced by tranexamic acid.
Topics: Acute Disease; Animals; Biomarkers; Blood Coagulation; Chromatography, High Pressure Liquid; Disease | 2019 |
Thrombotic cocktail in stroke.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Carotid Artery Thrombosis; Contraceptives, Oral, Hor | 2005 |